Evidence map›Paper›PMID 28507435›Full record

ArticleInternational journal of nanomedicine2017

Mesoporous silica nanoparticles trigger mitophagy in endothelial cells and perturb neuronal network activity in a size- and time-dependent manner.

Antonina Orlando, Emanuela Cazzaniga, Maria Tringali, Francesca Gullo, Andrea Becchetti, Stefania Minniti, Francesca Taraballi, Ennio Tasciotti, Francesca Re

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Toxicity evaluation of silica nanoparticles for delivery applications.Drug delivery and translational research · 2023
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Acute Exposure to SiONeurotoxicity research · 2020
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Antonina OrlandoNanomedicine Center, School of Medicine and Surgery, University of Milano-Bicocca, Monza.
Emanuela CazzanigaNanomedicine Center, School of Medicine and Surgery, University of Milano-Bicocca, Monza.
Maria TringaliDepartment of Environmental Sciences.
Francesca GulloDepartment of Biotechnologies and Biosciences, University of Milano-Bicocca, Milan, Italy.
Andrea BecchettiDepartment of Biotechnologies and Biosciences, University of Milano-Bicocca, Milan, Italy.
Stefania MinnitiNanomedicine Center, School of Medicine and Surgery, University of Milano-Bicocca, Monza.
Francesca TaraballiCenter for Biomimetic Medicine, Houston Methodist Research Institute (HMRI).
Ennio TasciottiCenter for Biomimetic Medicine, Houston Methodist Research Institute (HMRI).
Francesca ReNanomedicine Center, School of Medicine and Surgery, University of Milano-Bicocca, Monza.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeMesoporous silica nanoparticles (MSNPs) are excellent candidates for biomedical applications and drug delivery to different human body areas, the brain included. Although toxicity at cellular level has been investigated, we are still far from using MSNPs in the clinic, because the mechanisms involved in the cellular responses activated by MSNPs have not yet been elucidated. MATERIALS AND

methodsThis study used an in vitro multiparametric approach to clarify relationships among size, dose, and time of exposure of MSNPs (0.05-1 mg/mL dose range), and cellular responses by analyzing the morphology, viability, and functionality of human vascular endothelial cells and neurons.

resultsThe results showed that 24 hours of exposure of endothelial cells to 250 nm MSNPs exerted higher toxicity in terms of mitochondrial activity and membrane integrity than 30 nm MSN at the same dose. This was due to induced cell autophagy (in particular mitophagy), probably consequent to MSNP cellular uptake (>20%). Interestingly, after 24 hours of treatment with 30 nm MSNPs, very low MSNP uptake (<1%) and an increase in nitric oxide production (30%,

conclusionThese results suggest that MSNPs may be low-risk if prepared with a diameter <30 nm and if they reach human tissues at doses <0.25 mg/mL. These important advances could help the rational design of NPs intended for biomedical uses, demonstrating that careful toxicity evaluation is necessary before using MSNPs in patients.

Indexed as

AutophagyCell LineCell MembraneCell SurvivalDose-Response Relationship, DrugDrug Delivery SystemsElectrophoresis, Polyacrylamide GelEndothelial CellsEnzymesHumansHuman Umbilical Vein Endothelial CellsMitophagyNanoparticlesNeuronsNitric OxideSilicon DioxideEnzymesNitric OxideSilicon Dioxidebrainendothelial cellsmesoporous silica nanoparticlesnanotoxicityneurons

Identifiers

PMID28507435
PMCPMC5428814

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.